Renal Research Institute

Recent papers from Renal Research Institute

1. The Future of Dialysis and Kidney Xenotransplantation: Promise, Cost, and Barriers to ImplementationJournal of Clinical Medicine · 2026
2. Pulmonary hypertension and right ventricular dysfunction in hemodialysis: an overlooked cardiorenal interface and a target for dialysis prescriptionJournal of Hypertension · 2026
3. One estimated glomerular filtration rate, many diseases: What remains beyond filtration‐based classification of chronic kidney disease?Journal of Internal Medicine · 2026
4. Longitudinal albumin and blood pressure trajectories identify mortality risk phenotypes in hemodialysisBMC Nephrology · 2026
5. Microbiome Science at the Kidney–Vascular Interface: Why Translation to Diagnostics and Therapies Still Lags BehindClinical Kidney Journal · 2026
6. Online high-dose hemodiafiltration: a path towards improved clinical outcomes and green dialysisCurrent Opinion in Nephrology & Hypertension · 2026
7. Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic StrategiesNephrology Dialysis Transplantation · 2026
8. New potassium binders: we need them - we do not need themClinical Kidney Journal · 2026
9. Cloud-Based AI Application for Classifying Arteriovenous Hemodialysis Vascular Access AneurysmsClinical Journal of the American Society of Nephrology · 2026
10. Beyond Kt/V: Redefining Dialysis Adequacy as Targeted Cardiovascular Risk ReductionNephrology Dialysis Transplantation · 2026
11. Effects of Sodium‐Glucose Cotransporter‐2 Inhibitors on Inflammatory Biomarkers: A Systematic Review and Meta‐AnalysisDiabetes Obesity and Metabolism · 2026
12. Toward Precision Fluid Management in Hemodialysis: Adaptive Ultrafiltration Guided by Continuous Relative Blood Volume MonitoringJournal of Clinical Medicine · 2026
13. Study protocol for a target trial emulation: CHoosing the right diAlysis Modality in clinical PractIce: hemOdiafiltratioN or hemodialysis (CHAMPION)BMC Nephrology · 2026
14. Endothelin receptor antagonism for resistant hypertension in chronic kidney disease: where does aprocitentan fit?Clinical Kidney Journal · 2026
15. Pragmatic Clinical Trials in Internal Medicine: Design Principles and Context‐Specific ImplementationEuropean Journal of Clinical Investigation · 2026
16. Sudden cardiac death in chronic kidney disease and dialysis: From descriptive epidemiology to mechanism‐driven preventionJournal of Internal Medicine · 2026
17. Drugs lost in translation in CKD: from redundant designs to learning systems.2026
18. Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial designNephrology Dialysis Transplantation · 2026
19. Hemodiafiltration versus High-flux Hemodialysis and Risk of MortalityJournal of the American Society of Nephrology · 2026
20. PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertaintiesClinical Kidney Journal · 2026